The Plot Thickens: More on Belatacept Outcomes in Obesity

from The mTOR You Know · host The mTOR You Know

Drs. Nick Lange and Dave Salerno join us to discuss their team's recently published paper taking an in-depth look at the relationship between obesity and outcomes in patients on belatacept-based immunosuppression. To follow along, their article can be found via the following citation: Lange NW, King K, Husain SA, Salerno DM, Tsapepas DS, Hedvat J, Yu M, Mohan S. Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials. Am J Transplant. 2024 Jun;24(6):1027-1034. doi: 10.1016/j.ajt.2024.02.015. Epub 2024 Feb 21. PMID: 38387620. This episode is a follow-up to our December 2023 clinical debate on immunosuppression dosing in the setting of obesity. If you missed it or need a refresher, we encourage you to listen to that episode as well.

Episode metadata supplied by the publisher feed · Published Jan 14, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

The Plot Thickens: More on Belatacept Outcomes in Obesity

0:00 31:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The mTOR You Know?

This episode is 31 minutes long.

When was this The mTOR You Know episode published?

This episode was published on January 14, 2025.

Can I download this The mTOR You Know episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!